Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIFAMYCIN vs RIFAXIMIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIFAMYCIN vs RIFAXIMIN: Safety Overview

Metric RIFAMYCIN RIFAXIMIN
Total FAERS Reports 106 13,861
Deaths Reported 26 5,009
Death Rate 24.5% 36.1%
Hospitalizations 35 4,847
Average Patient Age 56.1 yrs 63.2 yrs
% Female Patients 54.5% 54.9%
FDA Approval Date Nov 16, 2018 Mar 24, 2010
Manufacturer N/A Salix Pharmaceuticals, Inc.
Route N/A ORAL
Marketing Status Discontinued Prescription